Biographical summary
Abhishek Mangaonkar, M.B.B.S., is an assistant professor of oncology and medicine at Mayo Clinic, and a consultant in the Division of Hematology. He received his medical degree from Grant Medical College and completed his residency in internal medicine at Medical College of Georgia, and his fellowship in hematology/oncology and blood and marrow transplant at Mayo Clinic. He is board certified in internal medicine, medical oncology and hematology.
Dr. Mangaonkar has a special interest in inherited bone marrow failure syndromes, myelodysplastic syndromes, and chronic myelomonocytic leukemia. He has published over 100 peer-reviewed articles, book chapters, and abstracts, and serves as an editorial board member and reviewer for several hematology journals.  He has received several awards and honors for his academic and research excellence, such as the Outstanding Research Fellow Award from Mayo Clinic, the Abstract Achievement Award from American Society of Hematology, and the Gold Medal in Surgery from Maharashtra University of Health Sciences. He is also involved in clinical and translational research projects, focusing on the immune microenvironment and clonal evolution of myeloid neoplasms, and the development of novel therapies for these disorders.
Complimentary to his clinical expertise, his key areas of research focus are: 
    - Immune dysregulation and tolerance mechanisms in myeloid leukemias.
- Mechanisms of clonal evolution in inherited bone marrow failure syndromes.
- Genomics of myeloid leukemias.
Conditions treated
        Procedures performed
        Interests
- Bone marrow failure disorders, specifically germline or inherited bone marrow failure syndromes such as telomere biology disorders, GATA2 haploinsufficiency syndrome, ribosomopathies, Fanconi anemia, Diamond-Blackfan Anemia, among others.
- Hereditary cancer predisposition syndromes, specifically hereditary predisposition to blood cancers.
- Clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenias of undetermined significance (CCUS).
- Allogeneic hematopoietic stem cell or bone marrow transplantation for bone marrow failure disorders and leukemias.
- Myeloid leukemias such as myelodysplastic syndromes (MDS), myelodysplastic/myeloproliferative (MDS/MPN) overlap neoplasms, myeloproliferative neoplasms (MPN), and acute myeloid leukemia (AML).
Mayo Clinic locations
        Education
- 2020SubSpec FellowBlood and Marrow Transplant, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine 
- 2019FellowHematology/Oncology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine 
- 2016Residency - Internal MedicineDepartment of Medicine, Medical College of Georgia 
- 2012MBBSGrant Medical College and Sir J.J Group of Hospitals 
Activities and honors
Certifications
- 2020HematologyAmerican Board of Internal Medicine 
- 2019Medical OncologyAmerican Board of Internal Medicine 
- 2016Internal MedicineAmerican Board of Internal Medicine 
Awards and honors
- 2020Abstract Achievement AwardAmerican Society of Hematology 
- 2019Outstanding Hematology-Oncology Trainee, Department of Medicine, Mayo ClinicMayo School of Graduate Medical Education 
- 2019Outstanding Research FellowDepartment of Medicine 
- 2018Travel GrantEuropean Hematology Association 
- 2018Outstanding Fellow AwardThe Minnesota Society of Clinical Oncology 
- 2015Rahn-Peacock Excellence in Research AwardMedical College of Georgia 
- 2015James R Lyle Resident Research AwardRichmond County Medical Society 
- 2012Gold Medal (Top rank in surgery)Maharashtra University of Health Sciences 
- 2007Excellence in Academics AwardGrant Medical College 
- 2004Sir Ratan Tata ScholarshipCentral Board of Secondary Education 
Professional memberships
- 2020 - presentProject FacilitatorIMP Committee, Mayo Clinic Center for Individualized Medicine 
- 2020 - presentReview Panel MemberMayo Clinic Center for Individualized Medicine 
Publications
Research activities